{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:57:21Z","timestamp":1772585841425,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["23CDA1053072"],"award-info":[{"award-number":["23CDA1053072"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01AG077038"],"award-info":[{"award-number":["K01AG077038"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK109102"],"award-info":[{"award-number":["R01DK109102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002223"],"award-info":[{"award-number":["BX002223"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estrogen therapy and androgen\u2011deprivation were once combined to treat prostate cancer (PrCa). Clinical studies later showed that prolonged estrogen exposure in androgen\u2011deprived men raises cardiovascular disease (CVD) risk, yet the metabolic pathways responsible remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We generated an androgen\u2011deprived, 17\u03b2\u2011estradiol (E2)\u2013treated mouse model by gonadectomizing male C57BL\/6\u00a0J mice and implanting sub\u2011cutaneous delayed\u2011release E2 or vehicle pellets. Mice received a Western\u2011style diet and were housed at thermoneutrality to accelerate CVD\u2011risk phenotypes. Metabolic profiling included hyperinsulinemic\u2011euglycemic clamps, oral lipid and pyruvate tolerance tests, flow cytometry of immune cells, and single\u2011nucleus RNA sequencing of liver tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In hypogonadal males, E2 treatment induced several metabolic disturbances. During clamps, E2\u2011treated mice showed markedly elevated gluconeogenesis, corroborated by higher glucose peaks and AUC during pyruvate tolerance testing and by up\u2011regulation of hepatic\u00a0Pck1 mRNA. Triglyceride (TG) clearance, which improves with E2 in females, was impaired in E2\u2011treated males: oral lipid\u2011tolerance testing revealed prolonged TG excursions, reduced maximal lipase activity, lower non\u2011lipase clearance at\u00a06\u00a0h post-OLTT, and decreased free\u2011fatty\u2011acid peak levels. Hepatic lipase, VLDL clearance receptors Ldlr and Lrp1, and microsomal triglyceride transfer protein (MTP) transcripts were down\u2011regulated. SnRNA\u2011seq showed suppression of lipid\u2011clearance genes with E2 treatment in males. Subcutaneous adipocytes were hypertrophic, and flow cytometry identified increased TNF\u03b1\u2011positive macrophages, an inflammatory milieu that could promote insulin resistance. Cardiac morphology was modestly altered; E2\u2011treated males exhibited a larger left\u2011ventricular end\u2011diastolic diameter, while ejection fraction and arterial pressure remained unchanged.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Estradiol administration in androgen\u2011deprived male mice produces a constellation of metabolic derangements\u2014including enhanced hepatic gluconeogenesis, impaired TG clearance, and inflammatory adipocyte hypertrophy\u2014that likely underlie the increased CVD risk observed clinically. The identified molecular nodes (PEPCK, hepatic lipase, LRP1, LDLR, MTP, and adipose\u2011macrophage TNF\u03b1) provide potential targets for mitigating estrogen\u2011induced CVD risk while preserving its therapeutic benefit for PrCa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-025-03059-y","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T02:25:12Z","timestamp":1769999112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex\u2011specific cardiovascular risk in estrogen\u2011treated androgen\u2011deprived males: metabolic characterization of glucose, adipose, and lipid pathways"],"prefix":"10.1186","volume":"25","author":[{"given":"Ariel S.","family":"Thorson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey Pinckard","family":"Schaefers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget","family":"Litts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Rein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Adapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivaprakasam","family":"Chinnarasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Recupido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyla J.","family":"Streng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruirui","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Pierre-Louis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drucilla","family":"Forson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Luviano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet","family":"Kirabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"M Stafford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"5","key":"3059_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1530\/EJE-11-0447","volume":"165","author":"G Corona","year":"2011","unstructured":"Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol. 2011;165(5):687\u2013701.","journal-title":"Eur J Endocrinol"},{"issue":"15","key":"3059_CR2","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1093\/eurjpc\/zwac133","volume":"29","author":"MA Karalexi","year":"2022","unstructured":"Karalexi MA, Frisell T, Cnattingius S, Holmberg D, Holmberg M, Kollia N, et al. Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy. Eur J Prev Cardiol. 2022;29(15):2017\u201326.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"3059_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011;164(4):635\u201342.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"3059_CR4","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nrendo.2017.12","volume":"13","author":"E Morselli","year":"2017","unstructured":"Morselli E, Santos RS, Criollo A, Nelson MD, Palmer BF, Clegg DJ. The effects of oestrogens and their receptors on cardiometabolic health. Nat Rev Endocrinol. 2017;13(6):352\u201364.","journal-title":"Nat Rev Endocrinol"},{"key":"3059_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ahj.2020.03.016","volume":"224","author":"WE Boden","year":"2020","unstructured":"Boden WE, Miller MG, McBride R, Harvey C, Snabes MC, Schmidt J, et al. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease. Am Heart J. 2020;224:65\u201376.","journal-title":"Am Heart J"},{"issue":"5","key":"3059_CR6","first-page":"679","volume":"4","author":"PL Nguyen","year":"2021","unstructured":"Nguyen PL, Hsu JC. Cardiovascular outcomes of estrogen therapy in men undergoing androgen deprivation for prostate cancer: a population-based cohort. Eur Urol Oncol. 2021;4(5):679\u201388.","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"3059_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.2337\/db11-1718","volume":"62","author":"L Zhu","year":"2013","unstructured":"Zhu L, Brown WC, Cai Q, Krust A, Chambon P, McGuinness OP, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes. 2013;62(2):424\u201334.","journal-title":"Diabetes"},{"key":"3059_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","volume":"1043","author":"BT Palmisano","year":"2017","unstructured":"Palmisano BT, Zhu L, Stafford JM. Role of estrogens in the regulation of liver lipid metabolism. Adv Exp Med Biol. 2017;1043:227\u201356.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"3059_CR9","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ijo.2017.50","volume":"41","author":"S Hart-Unger","year":"2017","unstructured":"Hart-Unger S, Arao Y, Hamilton KJ, Lierz SL, Malarkey DE, Hewitt SC, et al. Hormone signaling and fatty liver in females: analysis of estrogen receptor \u03b1 mutant mice. Int J Obes. 2017;41(6):945\u201354.","journal-title":"Int J Obes"},{"key":"3059_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.889923","volume":"13","author":"BM Steiner","year":"2022","unstructured":"Steiner BM, Berry DC. The regulation of adipose tissue health by estrogens. Front Endocrinol. 2022;13:889923.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3059_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.amjmed.2015.08.010","volume":"129","author":"HS Kahn","year":"2016","unstructured":"Kahn HS, Bullard KM. Beyond body mass index: advantages of abdominal measurements for recognizing cardiometabolic disorders. Am J Med. 2016;129(1):74-81.e2.","journal-title":"Am J Med"},{"key":"3059_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2023.101746","volume":"74","author":"A Gupta","year":"2023","unstructured":"Gupta A, Efthymiou V, Kodani SD, Shamsi F, Patti ME, Tseng YH, et al. Mapping the transcriptional landscape of human white and brown adipogenesis using single-nuclei RNA-seq. Mol Metabol. 2023;74:101746.","journal-title":"Mol Metabol"},{"issue":"10","key":"3059_CR13","doi-asserted-by":"publisher","first-page":"7845","DOI":"10.3390\/cimb45100496","volume":"45","author":"T Ciarambino","year":"2023","unstructured":"Ciarambino T, Crispino P, Guarisco G, Giordano M. Gender differences in insulin resistance: new knowledge and perspectives. Curr Issues Mol Biol. 2023;45(10):7845\u201361.","journal-title":"Curr Issues Mol Biol"},{"issue":"6","key":"3059_CR14","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s11255-018-1854-5","volume":"50","author":"LO Reis","year":"2018","unstructured":"Reis LO, Zani EL, Garc\u00eda-Perdomo HA. Estrogen therapy in patients with prostate cancer: a contemporary systematic review. Int Urol Nephrol. 2018;50(6):993\u20131003.","journal-title":"Int Urol Nephrol"},{"issue":"26","key":"3059_CR15","first-page":"249","volume":"2","author":"JC Bailar","year":"1970","unstructured":"Bailar JC, Byer DP. Estrogen treatment for cancer of the prostate. Early results with 3 doses of diethylstilbestrol and placebo. Cancer. 1970;2(26):249\u201388.","journal-title":"Cancer"},{"issue":"5","key":"3059_CR16","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/1097-0142(197311)32:5<1126::AID-CNCR2820320518>3.0.CO;2-C","volume":"32","author":"DP Byer","year":"1970","unstructured":"Byer DP. The veterans administration cooperative urological research group\u2019s studies of cancer of the prostate. Cancer. 1970;32(5):1126\u201330.","journal-title":"Cancer"},{"key":"3059_CR17","unstructured":"Herman, J.\u00a0L., Flores, A.\u00a0R., &\u00a0O\u2019Neill, K.\u00a0K. (2022). How Many Adults and Youth Identify as Transgender in the United States? Williams Institute, UCLA School of Law."},{"key":"3059_CR18","unstructured":"European Union Agency for Fundamental Rights. (2014). Transgender people in Europe: Comparative analysis of EU LGBT survey data."},{"issue":"4","key":"3059_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jadohealth.2021.10.036","volume":"70","author":"AE Green","year":"2022","unstructured":"Green AE, DeChants JP, Price MN, Davis CK. Association of gender-affirming hormone therapy with depression, thoughts of suicide, and attempted suicide among transgender and nonbinary youth. J Adolesc Health. 2022;70(4):643\u20139.","journal-title":"J Adolesc Health"},{"key":"3059_CR20","unstructured":"Lilly Research Laboratories et\u00a0al. (2000). Withdrawal of approval of 28 new drug applications. Federal Register."},{"issue":"3","key":"3059_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0955","volume":"8","author":"SL Reisner","year":"2025","unstructured":"Reisner SL, Pletta DR, Keuroghlian AS, Mayer KH, Deutsch MB, Potter J, et al. Gender-affirming hormone therapy and depressive symptoms among transgender adults. JAMA Netw Open. 2025;8(3):e250955.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"3059_CR22","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S2213-8587(21)00185-6","volume":"9","author":"CJ de Blok","year":"2021","unstructured":"de Blok CJ, Wiepjes CM, van Velzen DM, et al. Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria. Lancet Diabetes Endocrinol. 2021;9(10):663\u201370.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"3059_CR23","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1210\/jcem.86.9.7851","volume":"86","author":"JC Smith","year":"2001","unstructured":"Smith JC, Bennett S, Evans LM, Kynaston HG, Parmar M, Mason MD, et al. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab. 2001;86(9):4261\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3059_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4330\/wjc.v4.i4.90","volume":"4","author":"Z Hegab","year":"2012","unstructured":"Hegab Z, Gibbons S, Neyses L, Mamas MA. Role of advanced glycation end products in cardiovascular disease. World J Cardiol. 2012;4(4):90\u2013102.","journal-title":"World J Cardiol"},{"issue":"9","key":"3059_CR25","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2337\/diacare.22.9.1543","volume":"22","author":"BK Kilhovd","year":"1999","unstructured":"Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care. 1999;22(9):1543\u20138.","journal-title":"Diabetes Care"},{"issue":"1","key":"3059_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/bc034083v","volume":"15","author":"FK Yeboah","year":"2004","unstructured":"Yeboah FK, Alli I, Yaylayan VA, Yasuo K, Chowdhury SF, Purisima EO. Effect of limited solid-state glycation on the conformation of lysozyme by ESI-MS\/MS peptide mapping and molecular modeling. Bioconjug Chem. 2004;15(1):27\u201334.","journal-title":"Bioconjug Chem"},{"issue":"1","key":"3059_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41391-018-0079-0","volume":"22","author":"ED Crawford","year":"2019","unstructured":"Crawford ED, Heidenreich A, Lawrentschuk N, et al. Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations. Prostate Cancer Prostatic Dis. 2019;22(1):24\u201338.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"3059_CR28","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. (2011). Guide for the care and use of laboratory animals (8th ed.). National Academies Press."},{"issue":"8","key":"3059_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nrendo.2017.48","volume":"13","author":"K Ganeshan","year":"2017","unstructured":"Ganeshan K, Chawla A. Warming the mouse to model human diseases. Nat Rev Endocrinol. 2017;13(8):458\u201365.","journal-title":"Nat Rev Endocrinol"},{"key":"3059_CR30","unstructured":"Flecknell, P. A. Laboratory Animal Anaesthesia\u00a0: An Introduction for Research Workers and Technicians. London. San Diego: Academic Press, 1987. Print."},{"key":"3059_CR31","first-page":"123","volume":"470","author":"JE Ayala","year":"2010","unstructured":"Ayala JE, Bracy DP, McGuinness OP. Hyperinsulinemic\u2011euglycemic clamps in conscious, unrestrained mice. Methods Enzymol. 2010;470:123\u201344.","journal-title":"Methods Enzymol"},{"issue":"2","key":"3059_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/and.12610","volume":"49","author":"MA De Smet","year":"2017","unstructured":"De Smet MA, Lapauw B, De Backer T. Sex steroids in relation to cardiac structure and function in men. Andrologia. 2017;49(2):10.1111\/and.12610.","journal-title":"Andrologia"},{"key":"3059_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng GXY, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:1\u201312. https:\/\/doi.org\/10.1038\/ncomms14049.","journal-title":"Nat Commun"},{"key":"3059_CR34","doi-asserted-by":"crossref","unstructured":"Stephen J Fleming, Mark D Chaffin, Alessandro Arduini, Amer-Denis Akkad, Eric Banks, John C Marioni, Anthony A Philippakis, Patrick T Ellinor, and Mehrtash Babadi. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nature Methods, 2023.","DOI":"10.1038\/s41592-023-01943-7"},{"issue":"2","key":"3059_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2023","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2023;42(2):293\u2013304.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"3059_CR36","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.cell.2018.05.012","volume":"173","author":"X Han","year":"2018","unstructured":"Han X, Wang R, Zhou Y, Fei L, Sun H, Lai S, et al. Mapping the mouse cell atlas by Microwell-Seq. Cell. 2018;173(5):1307.","journal-title":"Cell"},{"key":"3059_CR37","doi-asserted-by":"crossref","unstructured":"Guilliams, M., Bonnardel, J., Haest, B., Vanderborght, B., Bujko, A., Martens, L., Thon\u00e9, T., Browaeys, R., De Ponti, F. F., Remmerie, A., Wagner, C., Vanneste, B., Zwicker, C., Vanhalewyn, T., Gon\u00e7alves, A., Lippens, S., Devriendt, B., Cox, E., Ferrero, G., \u2026 Scott, C. L. (2021). Spatial Proteogenomics Reveals Distinct and Evolutionarily-Conserved Hepatic Macrophage Niches.","DOI":"10.1101\/2021.10.15.464432"},{"issue":"1","key":"3059_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jcmgh.2020.07.012","volume":"11","author":"R Nault","year":"2021","unstructured":"Nault R, Fader KA, Bhattacharya S, Zacharewski TR. Single-nuclei RNA sequencing assessment of the hepatic effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin. Cell Mol Gastroenterol Hepatol. 2021;11(1):147\u201359.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3059_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nm.3695","volume":"20","author":"A Kirabo","year":"2014","unstructured":"Kirabo A, et al. Inflammation-driven hypertension: a role for T-cell activation and cytokine production. Nat Med. 2014;20:1279\u201388. https:\/\/doi.org\/10.1038\/nm.3695.","journal-title":"Nat Med"},{"issue":"1","key":"3059_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/21623945.2022.2027610","volume":"11","author":"VA Palom\u00e4ki","year":"2022","unstructured":"Palom\u00e4ki VA, Koivukangas V, Meril\u00e4inen S, Lehenkari P, Karttunen TJ. A straightforward method for adipocyte size and count analysis using open-source software QuPath. Adipocyte. 2022;11(1):99\u2013107.","journal-title":"Adipocyte"},{"issue":"2","key":"3059_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-17-0496","volume":"178","author":"M Klaver","year":"2018","unstructured":"Klaver M, de Blok CJM, Wiepjes CM, Nota NM, Dekker MJHJ, et al. Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. Eur J Endocrinol. 2018;178(2):163\u201371.","journal-title":"Eur J Endocrinol"},{"key":"3059_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1187735","volume":"10","author":"A Cesaro","year":"2023","unstructured":"Cesaro A, De\u00a0Michele G, Fimiani F, et al. Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options. Front Cardiovasc Med. 2023;10:1187735.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3059_CR43","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00125-015-3810-6","volume":"59","author":"JR Acosta","year":"2016","unstructured":"Acosta JR, Douagi I, Andersson DP, B\u00e4ckdahl J, Ryd\u00e9n M, Arner P, et al. Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes. Diabetologia. 2016;59(3):560\u201370.","journal-title":"Diabetologia"},{"issue":"5","key":"3059_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","volume":"58","author":"JM Elbers","year":"2003","unstructured":"Elbers JM, Giltay EJ, Teerlink T, et al. Effects of sex steroids on components of the insulin-resistance syndrome in transsexual subjects. Clin Endocrinol. 2003;58(5):562\u201371.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"3059_CR45","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1200\/JCO.1996.14.8.2250","volume":"14","author":"A Chang","year":"1996","unstructured":"Chang A, Yeap B, Davis T, et al. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol. J Clin Oncol. 1996;14(8):2250\u20137.","journal-title":"J Clin Oncol"},{"issue":"Issue 5","key":"3059_CR46","doi-asserted-by":"publisher","first-page":"e2000","DOI":"10.1210\/clinem\/dgab934","volume":"Volume 107","author":"D van Velzen","year":"2022","unstructured":"van Velzen D, Wiepjes C, Nota N, van Raalte D, de Mutsert R, Simsek S, et al. Incident diabetes risk is not increased in transgender individuals using hormone therapy. J Clin Endocrinol Metab. 2022;Volume 107(Issue 5):e2000\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"3059_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2021.03.008","volume":"323","author":"DM van Velzen","year":"2021","unstructured":"van Velzen DM, Adorni MP, Zimetti F, Strazzella A, Simsek S, Sirtori CR, et al. The effect of transgender hormonal treatment on high density lipoprotein cholesterol efflux capacity. Atherosclerosis. 2021;323:44\u201353.","journal-title":"Atherosclerosis"},{"issue":"10","key":"3059_CR48","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00109-025-02577-2","volume":"103","author":"DS Escudero","year":"2025","unstructured":"Escudero DS, Mart\u00ednez VR, Pirosanto Y, Colareda GA, Diez MP, Lofeudo JM, et al. Cardiovascular risk of gender-affirming estrogen therapy in a transgender rat model. J Mol Med (Berl). 2025;103(10):1205\u201317.","journal-title":"J Mol Med (Berl)"},{"key":"3059_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.799096","volume":"12","author":"L Zhu","year":"2022","unstructured":"Zhu L, An J, Chinnarasu S, Luu T, Pettway YD, Fahey K, et al. Expressing the human cholesteryl ester transfer protein minigene improves diet-induced fatty liver and insulin resistance in female mice. Front Physiol. 2022;12:799096.","journal-title":"Front Physiol"},{"issue":"5","key":"3059_CR50","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/JU.0000000000000684","volume":"203","author":"AB Weiner","year":"2020","unstructured":"Weiner AB, Cohen JE, DeLancey JO, Schaeffer EM, Auffenberg GB. Surgical versus medical castration for metastatic prostate cancer: use and overall survival in a national cohort. J Urol. 2020;203(5):933\u20139.","journal-title":"J Urol"},{"issue":"1","key":"3059_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.18773\/austprescr.2019.003","volume":"42","author":"L Tomlins","year":"2019","unstructured":"Tomlins L. Prescribing for transgender patients. Aust Prescr. 2019;42(1):10\u20133. https:\/\/doi.org\/10.18773\/austprescr.2019.003.","journal-title":"Aust Prescr"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-03059-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-03059-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:06:25Z","timestamp":1772582785000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-025-03059-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-03059-y","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were performed in accordance with National Institutes of Health Guidelines for the Care and Use of Animals and approved by the Institutional Animal Care and Use Committee at Vanderbilt University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent for publication of the manuscript above, including accompanying images or data contained therein.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}